Contents
Overview
The Database of Genomic Variants was established to address the growing need for a centralized repository of human genomic variations, which are essential for understanding the genetic basis of human disease. This database is maintained by the Centre for Applied Genomics, a genome centre located in the Peter Gilgan Centre for Research and Learning in downtown Toronto, Canada, and is affiliated with the University of Toronto. The centre's research focuses on the genetic and genomic basis of human variability, health, and disease, including the genetics of autism spectrum disorder and structural variation of the human genome. By collaborating with other research institutions, such as the National Institutes of Health and the Wellcome Sanger Institute, the Centre for Applied Genomics ensures that the database remains a comprehensive and up-to-date resource for the scientific community.
📊 How It Works
The database operates as a Science and Technology Innovation Centre of Genome Canada, with an emphasis on next-generation sequencing (NGS) and bioinformatics support. This enables researchers to analyze and interpret large amounts of genomic data, which is critical for identifying genetic variants associated with specific diseases. For example, the database has been used to study the genetic basis of cancer and neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. By leveraging the database and other resources, such as the Human Genome Project, researchers can develop more effective treatments and therapies for these conditions.
🌐 Cultural Impact
The Database of Genomic Variants has had a significant impact on the field of genetics and genomics, enabling researchers to better understand the complexities of human genetics and develop more effective treatments for genetic disorders. The database has also facilitated collaboration among researchers, clinicians, and industry partners, such as Illumina and Thermo Fisher Scientific, promoting the translation of genomic research into clinical practice. As the field of genomics continues to evolve, the database will remain a vital resource for researchers, clinicians, and patients, providing access to the latest information on genomic variants and their associations with human disease. For instance, the database has been used to develop personalized medicine approaches, such as precision medicine, which tailor treatments to an individual's unique genetic profile.
🔮 Legacy & Future
As the Database of Genomic Variants continues to grow and evolve, it is likely to play an increasingly important role in shaping the future of genetics and genomics research. With the advent of new technologies, such as artificial intelligence and machine learning, the database will be able to provide even more detailed and accurate information on genomic variants and their associations with human disease. This will enable researchers to develop more effective treatments and therapies, and ultimately improve patient outcomes. The database will also continue to facilitate collaboration among researchers, clinicians, and industry partners, promoting the translation of genomic research into clinical practice and driving innovation in the field of genomics. For example, the database could be used to develop new diagnostic tools, such as genetic testing, which could help identify individuals at risk of developing certain diseases.
Key Facts
- Year
- 2007
- Origin
- Toronto, Canada
- Category
- chronic-conditions
- Type
- database
Frequently Asked Questions
What is the Database of Genomic Variants?
The Database of Genomic Variants is a comprehensive repository of human genomic variations, providing access to a vast collection of genomic variants and their associations with various health conditions. It is maintained by the Centre for Applied Genomics and is affiliated with the University of Toronto.
How is the database used in research?
The database is used to analyze and interpret large amounts of genomic data, which is critical for identifying genetic variants associated with specific diseases. Researchers can use the database to study the genetic basis of cancer and neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.
What are the implications of the database for personalized medicine?
The database has the potential to revolutionize personalized medicine by providing access to detailed information on genomic variants and their associations with human disease. This information can be used to develop targeted treatments and therapies, and ultimately improve patient outcomes. For example, the database could be used to develop new diagnostic tools, such as genetic testing, which could help identify individuals at risk of developing certain diseases.
How does the database facilitate collaboration among researchers?
The database facilitates collaboration among researchers, clinicians, and industry partners by providing a centralized repository of genomic variants and their associations with human disease. This enables researchers to share data and results, and promotes the translation of genomic research into clinical practice. For instance, the database has been used to develop new treatments for rare diseases, such as cystic fibrosis and sickle cell anemia.
What are the future directions of the database?
The database will continue to evolve and grow, with the advent of new technologies, such as artificial intelligence and machine learning. This will enable researchers to develop more effective treatments and therapies, and ultimately improve patient outcomes. The database will also continue to facilitate collaboration among researchers, clinicians, and industry partners, promoting the translation of genomic research into clinical practice and driving innovation in the field of genomics.